THERAPY BY MS
Timeline
8 events since 2023Board
Capital
Filings
Financial
Establishments
2023202420252026
The 2026 accounts are due by 31-07-2027.
2026
Annual accounts 2025 filed NBBmicro format · 11 days before the deadline
Transfer of 49 shares from to appointed as director · holds 51 shares · holds 49 shares · General meeting of 02-02-20266 points ▸
- General meeting of 02-02-2026
- appointed as director
- Share transfer, , 49 shares
- holds 51 shares
- holds 49 shares
- Power of attorney granted to
2025
Weakest financial year net -€13,116 The net result drops to -€13,116, the lowest from 2023 to 2025.
Annual accounts 2024 filed PDFmicro format · 6 days before the deadline
2024
Back to profit net €2,927 The net result is €2,927, after one loss-making year.
Annual accounts 2023 filed PDFmicro format · 1 day before the deadline
2023
IncorporationFounding capital of €1,000, 100 shares · Founded by (mandate holder) · appointed as director · published on 06-03-20235 points ▸
- Founded by (mandate holder)
- The founding capital is €1,000, divided into 100 shares
- The registered office is at Rue François Vekemans 151, 1120 Bruxelles (Neder-Over-Heembeek)
- appointed as director, not named in the articles
- Power of attorney granted to
- The deed holds 1 more point.
First establishment Frans Vekemansstraat 151, Brussels
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank